Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.

MLA

Deuter, Christoph M. E., et al. “Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.” Ocular Immunology & Inflammation, vol. 25, no. 2, Apr. 2017, pp. 215–20. EBSCOhost, https://doi.org/10.3109/09273948.2015.1099680.

APA

Deuter, C. M. E., Zierhut, M., Igney-Oertel, A., Xenitidis, T., Feidt, A., Sobolewska, B., Stuebiger, N., & Doycheva, D. (2017). Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment. Ocular Immunology & Inflammation, 25(2), 215–220. https://doi.org/10.3109/09273948.2015.1099680

Chicago

Deuter, Christoph M. E., Manfred Zierhut, Annette Igney-Oertel, Theodoros Xenitidis, Alexandra Feidt, Bianka Sobolewska, Nicole Stuebiger, and Deshka Doycheva. 2017. “Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.” Ocular Immunology & Inflammation 25 (2): 215–20. doi:10.3109/09273948.2015.1099680.